Thought leaders from around the world contribute their perspectives on landmark cases, new legislation, and legal perspectives on new technologies, business practices, and civil procedure.
Robyn Shapiro of Health Sciences Law Group shares about her work and achievements in the health care law sector.
Michelle V. Rafter
While overall business bankruptcies dropped 5.4 percent through Q3, in excess of 300 stores filed for Chapter 7 or 11 in the same period, including big names like Toys “R” Us, Gymboree, and Payless ShoeSource.
What are legal rankings, and how can you get your name in the top spot?
Bradley L. Ortman
Last month, the DHS implemented a new rule to systematize its efforts to monitor social media use of intending immigrants and travelers to the United States.
Deborah Epstein Henry
A Fresh Twist on Innovation
The era of "no comment" to social and political questions is over. But what risk does the rise of so-called activist CEOs hold for a company?
The first step for a company looking to go public is to assess its viability by establishing whether or not it has the critical mass required to be a publically traded entity.
Trademark clearance for craft breweries.
John W.H. Denton AO
Globalization and technology are converging in a way that challenges orthodoxy.
Environmental Impact Bonds offer governments, investors and non-government participants the opportunity to focus on outcomes rather than activities.
When do you create a new service line?
Things to look for and things to avoid when choosing a medical expert for trial.
Start by identifying your target audience. Then, tailor your message to fit.
A Q&A with Ad Board member Andrey Goltsblat of Goltsblat BLP LLP discussing the legal climate in Russia.
Streamlining your networking process and tapping into local media resources are two ways to grow your client base.
Stephen G.A. Myers and Kelly E. Brilleaux
How will liability issues evolve as product liability lawsuits begin to surface involving 3D-printed products?
Joanna Barsh, Lauren Brown, and Kayvan Kian
Burden, blessing, or both?
Lawsuits about a blood-thinning drug that prevents platelets from clumping together now prevents plaintiffs from joining together to bring state law claims against a corporation when not every plaintiff was harmed in that state.
In Bristol-Myers Squibb Co. v. Superior Court of California, multiple plaintiffs sued Bristol-Myers Squibb Co. (BMS) in a California state court to recover damages allegedly caused by their use of BMS’ anti-clotting drug, Plavix.
To truly flourish, the smart cities of tomorrow must harness their data—but make sure they are doing so legally, ethically, and securely.
Alexis R. González-Pagani
Puerto Rico offers a variety of attractive incentives packages that cover multiple industry sectors.
Karen Gabriel Moss
USCIS is considering the reinterpretation of “may grant” language contained in the statute deeming it discretionary rather than mandatory.
Michelle V. Rafter
Plunging prices have decimated energy industry profits and jobs, but have given consumers more power at the pump.
"Profit with a purpose."
In this novel atmosphere of denials and obstacles, the damage is two-fold: our nation is not only denying its righteous legacy, but also its rightful destiny.
The Trump administration’s Muslim travel ban and its end of DACA (Deferred Action for Childhood Arrivals) attracted widespread comment and protest.